Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000827912 | SCV000969583 | likely benign | not provided | 2018-05-15 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001193333 | SCV001362084 | likely benign | not specified | 2019-12-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001435764 | SCV001638590 | likely benign | Andersen Tawil syndrome; Short QT syndrome type 3 | 2024-01-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002390720 | SCV002700011 | likely benign | Cardiovascular phenotype | 2020-01-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |